Fingerprint
Dive into the research topics of 'Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically